Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds

G Scalese, MF Mosquillo, L Pérez-Díaz… - Coordination Chemistry …, 2024 - Elsevier
Trypanosomatid parasites and fungi cause highly prevalent diseases. Ergosterol plays a
crucial role in the structure and normal function of the membrane of these microorganisms. It …

Multifunctional organometallic compounds for the treatment of Chagas disease: Re (i) tricarbonyl compounds with two different bioactive ligands

M Soba, G Scalese, F Casuriaga, N Pérez… - Dalton …, 2023 - pubs.rsc.org
Chagas' disease (American Trypanosomiasis) is an ancient and endemic illness in Latin
America caused by the protozoan parasite Trypanosoma cruzi. Although there is an urgent …

An overview of auric compounds as antimalarial agents and their action against essential targets of the parasite

GYS Delgado, M Navarro - Coordination Chemistry Reviews, 2024 - Elsevier
Malaria is one of the oldest and deadliest parasitic diseases globally, and it still poses a
global health issue today because of the emergence of new strains resistant to the first-line …

New multifunctional Ru (II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum

F Rivas, C Del Mármol, G Scalese, L Pérez-Díaz… - Journal of Inorganic …, 2022 - Elsevier
Human African trypanosomiasis (sleeping sickness) and leishmaniasis are prevalent
zoonotic diseases caused by genomically related trypanosomatid protozoan parasites …

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

S Previti, R Ettari, E Calcaterra, C Di Chio… - ACS Medicinal …, 2022 - ACS Publications
Human African Trypanosomiasis (HAT) is a neglected tropical disease widespread in sub-
Saharan Africa. Rhodesain, a cysteine protease of Trypanosoma brucei rhodesiense, has …

Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: Synthesis, characterization, and biological evaluation

CC de Souza, JA de Azevedo-França, E Barrias… - Journal of Inorganic …, 2023 - Elsevier
Currently the only drug available to treat Chagas disease in Brazil is benznidazole (BZN).
Therefore, there is an urgent need to discover and develop new anti-Trypanosoma cruzi …

Facing diseases caused by trypanosomatid parasites: rational design of multifunctional oxidovanadium (IV) complexes with bioactive ligands

G Scalese, I Machado, F Salazar, EL Coitiño… - Frontiers in Chemical …, 2024 - frontiersin.org
Searching for new prospective drugs against Chagas disease (American trypanosomiasis)
and Leishmaniasis, a series of five heteroleptic vanadium compounds,[VIVO (LH)(mpo)] …

Promising fluconazole based zinc (II) and copper (II) coordination polymers against Chagas disease

JA de Azevedo-França, E Barrias, CHJ Franco… - Journal of Inorganic …, 2022 - Elsevier
A series of new transition metal coordination polymers,[Zn (Ac) 2 (FLZ) 2] n (1),[Zn (FLZ) 2
(Cl) 2] n (2),{[Zn (FLZ) 2](NO 3) 2} n (3),[Cu (FLZ) 2 (CH₃COO) 4] n (4),{[Cu (FLZ) 2 Cl 2]} n …

Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru (II) Ferrocenyl Derivatives with Two Different Bioactive Ligands

F Rivas, C Del Mármol, G Scalese… - Inorganic …, 2024 - ACS Publications
Human African trypanosomiasis (HAT, sleeping sickness) and American trypanosomiasis
(Chagas disease) are endemic zoonotic diseases caused by genomically related …

Platinum and Palladium Organometallic Compounds: Disrupting the Ergosterol Pathway in Trypanosoma cruzi

F Mosquillo, G Scalese, R Moreira, PA Denis… - …, 2023 - Wiley Online Library
Current treatment for Chagas' disease is based on two drugs, Nifurtimox and Benznidazol,
which have limitations that reduce the effectiveness and continuity of treatment. Thus, there …